Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Hemangioma × Biopsy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 16 Prostatic Neoplasms 13 Carcinoma, Non-Small-Cell Lung 8 Colorectal Neoplasms 7 Pancreatic Neoplasms 6 Neoplasms 6 Melanoma 5 Lung Neoplasms 4 Head and Neck Neoplasms 4 Esophageal Neoplasms 4 Colonic Neoplasms 4 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Salivary Gland Neoplasms 3 Rectal Neoplasms 3 Ovarian Neoplasms 3 Myelodysplastic Syndromes 3 Multiple Myeloma 3 Lymphoma 3 Liver Neoplasms 3 Gastrointestinal Neoplasms 3 Gastritis, Atrophic 3 Barrett Esophagus 3 Adenocarcinoma Of Esophagus 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Small Cell Lung Carcinoma 2 Skin Neoplasms 2 Precancerous Conditions 2

Interventions

Urine Specimen Collection 1 Therapeutics 1 Steroids 1 Propranolol 1 Prednisolone 1 Observation 1 High-Energy Shock Waves 1 Hepatectomy 1 Blood Specimen Collection 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02334930 2016-08-22

PEC-Hem

University Hospital, Bordeaux

Hemangioma, Perivascular Epithelioid Cell Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡